Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

May 7, 2025

Study Completion Date

May 7, 2025

Conditions
OSA
Interventions
DRUG

AD109

Oral administration at bedtime.

DRUG

Placebo

Oral administration at bedtime.

Trial Locations (64)

11042

Northwell Health Physician Partners, New Hyde Park

15213

UPMC Comprehensive Lung Center - Sleep Medicine, Pittsburgh

19355

Brian Abaluck, LLC, Malvern

20854

Velocity Clinical Research, Rockville

21061

Sleep Disorders Centers of the Mid-Atlantic, Glen Burnie

22182

Sleep Disorders Centers of the Mid-Atlantic, Vienna

27607

Meridian Clinical Research, Raleigh

28037

Research Carolina Elite, Denver

28054

Clinical Research of Gastonia, Gastonia

28078

Advanced Respiratory and Sleep Medicine, LLC, Huntersville

28562

Coastal Carolina Health Care, New Bern

29406

Lowcountry Lung and Critical Care, Charleston

29615

Velocity Clinical Research - Greenville, Greenville

30030

CenExel iResearch, Decatur

30328

NeuroTrials Research, Atlanta

31210

Sleep Practitioners, LLC, Macon

31326

Centricity Research Rincon Pulmonology, Rincon

31605

Medster Research, Valdosta

32117

Arrow Clinical Trials, Daytona Beach

32789

Clinical Site Partners, LLC dba Flourish Research, Winter Park

33024

Cenexel Research Centers of America - Hollywood, Hollywood

33155

Ivetmar Medical Group LLC, Miami

33176

PharmaDev Clinical Research Institute, LLC, Miami

33189

Nouvelle Clinical Research, Cutler Bay

33409

Palm Beach Research ClinEdge-PPDS, West Palm Beach

33511

Teradan Clinical trials LLC, Brandon

33765

St. Francis Medical Institute, Clearwater

34470

Renstar Medical Research, Ocala

35213

Sleep Disorders Center of Alabama, Birmingham

38119

Clinical Neuroscience Solutions - Memphis, Memphis

43017

Ohio Sleep Medicine Institute, Dublin

44718

NeuroScience Research Center, LLC, Canton

45212

CTI Clinical Research Center, Cincinnati

45245

Sleep Management Institute, Cincinnati

48314

Clinical Neurophysiology Services, Sterling Heights

48377

Henry Ford Health (Sleep Research Department), Novi

49008

Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo

60634

Chicago Research Center Inc, Chicago

63017

St Lukes Hospital, Chesterfield

63042

Healthcare Research Network, Hazelwood

63123

Clayton Sleep Institute, St Louis

69101

Great Plains Health, North Platte

72211

Preferred Research Partners, Inc., Little Rock

78229

Sleep Therapy Research Center, San Antonio

78681

Central Texas Neurology Consultants, PA, Round Rock

78731

FutureSearch Trials of Neurology, Austin

80209

Mountain View Clinical Research, Inc., Denver

80301

Alpine Clinical Research Center, Boulder

85224

Chandler Clinical Trials, Chandler

87107

Maimonides Sleep Arts and Sciences, Albuquerque

89052

Henderson Clinical Trials, Henderson

90025

Santa Monica Clinical Trials, Los Angeles

90720

CenExel CNS, Los Alamitos

91767

Empire Clinical Research, Pomona

92103

Pacific Research Network, San Diego

92647

Marvel Clinical Research, LLC, Huntington Beach

92705

SDS Clinical Trials Inc., Santa Ana

92801

Orange County Research Institute, Anaheim

97202

Northwest Research Center, Portland

06850

Nuvance Health, Norwalk

02459

Neurocare, Inc, Newton

02747

Infinity Medical Research, North Dartmouth

01199

Baystate Medical Center (BMC) - Baystate Sleep Medicine, Springfield

07724

Clinilabs, Inc, Eatontown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Apnimed

INDUSTRY

NCT05811247 - Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) | Biotech Hunter | Biotech Hunter